NO890260L - Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten. - Google Patents

Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten.

Info

Publication number: NO890260L
Authority: NO; Norway
Prior art keywords: procedure; cytostatin; preparing; carrying; modifications
Prior art date: 1987-05-22

Application number

NO89890260A

Other languages

English (en)

Other versions

NO890260D0 (no

NO301985B1 (no

Inventor

Anders Grubb

Ke Lundwall

Magnus Abrahamson

Henrik Dalboege

Original Assignee

Nordisk Gentofte

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-22

Filing date

1989-01-20

Publication date

1989-01-20

1989-01-20 Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte

1989-01-20 Publication of NO890260L publication Critical patent/NO890260L/no

1989-01-20 Publication of NO890260D0 publication Critical patent/NO890260D0/no

1998-01-05 Publication of NO301985B1 publication Critical patent/NO301985B1/no

Links

238000000034 method Methods 0.000 title 2
PQNNIEWMPIULRS-UHFFFAOYSA-N Cytostatin Natural products CC=CC=CC=CC(O)C(C)C(OP(O)(O)=O)CCC(C)C1OC(=O)C=CC1C PQNNIEWMPIULRS-UHFFFAOYSA-N 0.000 title 1
108091028043 Nucleic acid sequence Proteins 0.000 title 1
PQNNIEWMPIULRS-SUTYWZMXSA-N [(8e,10e,12e)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)tetradeca-8,10,12-trien-5-yl] dihydrogen phosphate Chemical compound C\C=C\C=C\C=C\C(O)C(C)C(OP(O)(O)=O)CCC(C)C1OC(=O)C=CC1C PQNNIEWMPIULRS-SUTYWZMXSA-N 0.000 title 1
238000012986 modification Methods 0.000 title 1
102000012192 Cystatin C Human genes 0.000 abstract 4
108010061642 Cystatin C Proteins 0.000 abstract 4
108020004705 Codon Proteins 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
239000002299 complementary DNA Substances 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
210000005260 human cell Anatomy 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Electronic Switches (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

NO890260A 1987-05-22 1989-01-20 Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten NO301985B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK260987A DK260987D0 (da)	1987-05-22	1987-05-22	Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden
PCT/DK1988/000082 WO1988009384A1 (en)	1987-05-22	1988-05-20	Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method

Publications (3)

Publication Number	Publication Date
NO890260L true NO890260L (no)	1989-01-20
NO890260D0 NO890260D0 (no)	1989-01-20
NO301985B1 NO301985B1 (no)	1998-01-05

Family

ID=8113675

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO890260A NO301985B1 (no)	1987-05-22	1989-01-20	Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten

Country Status (12)

Country	Link
EP (1)	EP0362259B1 (no)
JP (1)	JP3011274B2 (no)
AT (1)	ATE135049T1 (no)
AU (1)	AU619750B2 (no)
CA (1)	CA1340862C (no)
DE (1)	DE3855078T2 (no)
DK (1)	DK260987D0 (no)
ES (1)	ES2013337A6 (no)
FI (1)	FI102191B (no)
IL (1)	IL86476A (no)
NO (1)	NO301985B1 (no)
WO (1)	WO1988009384A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2002820A1 (en) *	1988-11-18	1990-05-18	Kazunori Hanada	Pharmaceutical use for cystatins
GB9122051D0 (en) *	1991-10-17	1991-11-27	Univ Nottingham	Medicines
GB9403819D0 (en) *	1994-02-28	1994-04-20	Univ Leeds	Control of parasites
AU738766B2 (en) *	1994-11-21	2001-09-27	University Of Leeds, The	Modified proteinase inhibitors
CA2205356A1 (en) *	1994-11-21	1996-05-30	Peter Edward Urwin	Modified proteinase inhibitors
EP0842187A4 (en) *	1995-06-05	2000-04-12	Human Genome Sciences Inc	HUMANCYSTANIN E
US6011012A (en)	1995-06-05	2000-01-04	Human Genome Sciences, Inc.	Human cystatin E
EP1123399A2 (en) *	1998-08-05	2001-08-16	The University Of British Columbia	Production and use of modified cystatins
EP1147126A4 (en) *	1998-12-11	2003-07-09	Salk Inst For Biological Studi	CO FACTORS FOR TROPHIC FACTORS AND METHODS FOR THEIR USE
EP1176200A3 (de)	2000-06-20	2005-01-12	Switch Biotech Aktiengesellschaft	Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
JP6203723B2 (ja) *	2012-07-31	2017-09-27	雪印メグミルク株式会社	骨疾患の予防又は治療用タンパク質素材及びその製造方法
CN102895658A (zh) *	2012-08-23	2013-01-30	苏州大学附属第一医院	Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) *	2016-08-10	2016-11-16	吴江近岸蛋白质科技有限公司	表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4775624A (en) *	1985-02-08	1988-10-04	Eli Lilly And Company	Vectors and compounds for expression of human protein C

1987
- 1987-05-22 DK DK260987A patent/DK260987D0/da not_active Application Discontinuation
1988
- 1988-05-20 AT AT88904935T patent/ATE135049T1/de not_active IP Right Cessation
- 1988-05-20 ES ES8801999A patent/ES2013337A6/es not_active Expired - Lifetime
- 1988-05-20 DE DE3855078T patent/DE3855078T2/de not_active Expired - Lifetime
- 1988-05-20 WO PCT/DK1988/000082 patent/WO1988009384A1/en not_active Ceased
- 1988-05-20 JP JP63504682A patent/JP3011274B2/ja not_active Expired - Lifetime
- 1988-05-20 EP EP88904935A patent/EP0362259B1/en not_active Expired - Lifetime
- 1988-05-20 AU AU19399/88A patent/AU619750B2/en not_active Expired
- 1988-05-23 IL IL8647688A patent/IL86476A/en not_active IP Right Cessation
- 1988-05-24 CA CA000567916A patent/CA1340862C/en not_active Expired - Lifetime
1989
- 1989-01-20 NO NO890260A patent/NO301985B1/no not_active IP Right Cessation
- 1989-11-21 FI FI895553A patent/FI102191B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP3011274B2 (ja)	2000-02-21
DE3855078D1 (de)	1996-04-11
FI102191B1 (fi)	1998-10-30
DE3855078T2 (de)	1996-07-18
FI895553A0 (fi)	1989-11-21
ATE135049T1 (de)	1996-03-15
NO890260D0 (no)	1989-01-20
AU1939988A (en)	1988-12-21
DK260987D0 (da)	1987-05-22
IL86476A0 (en)	1988-11-15
FI102191B (fi)	1998-10-30
NO301985B1 (no)	1998-01-05
CA1340862C (en)	1999-12-28
ES2013337A6 (es)	1990-05-01
EP0362259A1 (en)	1990-04-11
JPH03501201A (ja)	1991-03-22
WO1988009384A1 (en)	1988-12-01
IL86476A (en)	1994-01-25
EP0362259B1 (en)	1996-03-06
AU619750B2 (en)	1992-02-06

Similar Documents

Publication	Publication Date	Title
NO890260D0 (no)	1989-01-20	Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten.
DE69013520D1 (de)	1994-11-24	Stabile integration von dna in bakterielle genome.
DE59002925D1 (de)	1993-11-04	Elektrolysezelle zur herstellung von peroxo- und perhalogenatverbindungen.
DE3864585D1 (de)	1991-10-10	Dns-molekule, codierend fuer non-a-non-b-hepatitis-antigene und ihre verwendung zur herstellung dieser antigene.
DE69214438D1 (de)	1996-11-14	Mehrstufiger bestrahlungsprozess zur herstellung von zusammensetzungen auf acrylbasis, und derartig hergestellte zusammensetzungen
DE3888274D1 (de)	1994-04-14	Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
DE69022595D1 (de)	1995-10-26	Herstellung von kohlefaser-halbfabrikaten.
FI852547L (fi)	1985-06-27	Framstaellning av faktor viii och daertill hoerande produkter.
ATE358176T1 (de)	2007-04-15	Menschliche dnase
NO873753D0 (no)	1987-09-08	Periodisk biologisk luftbehandlingsprosess og system for denne.
DE3872070D1 (de)	1992-07-23	Filter, das ein durch gefriertrocknung hergestelltes material enthaelt, herstellung und verwendung desselben, insbesondere in der galenik.
ATE27446T1 (de)	1987-06-15	Verfahren zur herstellung von 1,2,3-trichlor-2methyl-propan.
FI880383A0 (fi)	1988-01-28	Transformation och expression av en fraemmande gen i brassicaarter.
DE68916086D1 (de)	1994-07-21	Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
DE3260616D1 (en)	1984-10-04	Process of obtaining components of camomile by extraction with carbon dioxide
ES2054230T3 (es)	1994-08-01	Un proceso para la preparacion de un enterovirus o rinovirus atenuado.
ATE49185T1 (de)	1990-01-15	Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
DE68924222D1 (de)	1995-10-19	Megakaryocytopoietin, seine Herstellung und Benutzung.
ES554478A0 (es)	1987-09-01	Perfeccionamientos en los conuntos compuestos ordenados de membranas de filtracion, mejoras en los biorreactores con membrana de filtracion y procedimiento de tratamiento biologico y filtracion correspondiente
ATE81495T1 (de)	1992-10-15	Verfahren zur herstellung von natriumfluoralkoholaten.
ATE109509T1 (de)	1994-08-15	Anticoagulatorisches protein pp4-x, seine herstellung und verwendung.
DK583589A (da)	1990-01-19	Fremgangsmaade til fremstilling af cystatin c eller modifikationer heraf og dna-sekvens til brug ved udoevelse af fremgangsmaaden
DE69123344D1 (de)	1997-01-09	Künstliches blutgefäss sowie herstellung desselben
DE3882842D1 (de)	1993-09-09	Methode zur herstellung von cineolen.
DE3780665D1 (de)	1992-09-03	Mehrstufiges reduktionsverfahren zur herstellung von ferromagnetischem chromdioxid.

Legal Events

Date	Code	Title	Description
2008-06-23	MK1K	Patent expired